Literature DB >> 7110373

Monoamine oxidase of types A and B in the saphenous vein and mesenteric artery of the dog.

M M Caramona.   

Abstract

Homogenates of dog saphenous vein and mesenteric artery were prepared in phosphate buffer. Monoamine oxidase (MAO) activity was determined with 3H-5-hydroxytryptamine (3H-5-HT) as a preferential substrate for MAO type A, 14C-beta-phenylethylamine as a preferential substrate for MAO type B, and 3H-tyramine as a substrate for both MAO types. Km and Vmax for the different substrates were determined, and clorgyline and (-)-deprenyl were used as specific inhibitors. The endogenous noradrenaline content was compared with the activity of MAO in both blood vessels. The results show that the enzymatic deamination of tyramine is slightly but significantly higher in the mesenteric artery than in the saphenous vein. MAO A activity was significantly higher in the mesenteric artery than in the saphenous vein, but MAO B activity was the same in both vessels. Hence, the ratio MAO A activity/MAO B activity was greater for the mesenteric artery than for the saphenous vein. This difference may be related to the density of the adrenergic innervation of the two blood vessels.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110373     DOI: 10.1007/bf00503923

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

Review 1.  Multiple forms of monoamine oxidase: fact and artefact.

Authors:  M D Houslay; K F Tipton
Journal:  Life Sci       Date:  1976-08-15       Impact factor: 5.037

2.  Statistical estimations in enzyme kinetics.

Authors:  G N WILKINSON
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

3.  Inactivation of norepinephrine in an isolated vein.

Authors:  F Brandao
Journal:  J Pharmacol Exp Ther       Date:  1977-10       Impact factor: 4.030

Review 4.  Multiple forms of monoamine oxidase: functional significance.

Authors:  M Sandler; M B Youdim
Journal:  Pharmacol Rev       Date:  1972-06       Impact factor: 25.468

5.  Inactivation of endogenous noradrenaline released by electrical stimulation in vitro of dog saphenous vein.

Authors:  F Brandão; S Guimarães
Journal:  Blood Vessels       Date:  1974

6.  Monoamine oxidase in rat arteries: evidence for different forms and selective localization.

Authors:  J F Coquil; C Goridis; G Mack; N H Neff
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

7.  Some puzzling pharmacological effects of monoamine oxidase inhibitors.

Authors:  J Knoll; K Magyar
Journal:  Adv Biochem Psychopharmacol       Date:  1972

8.  Some observations upon a new inhibitor of monoamine oxidase in brain tissue.

Authors:  J P Johnston
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

9.  A comparative study of the uptake and metabolism of noradrenaline and adrenaline by the isolated saphenous vein of the dog.

Authors:  M Q Paiva; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-07       Impact factor: 3.000

10.  Monoamine oxidase A and B: a useful concept?

Authors:  T J Mantle; K F Tipton
Journal:  Biochem Pharmacol       Date:  1978-01-01       Impact factor: 5.858

View more
  12 in total

1.  Evidence for a non-precursor dopamine pool in noradrenergic neurones of the dog mesenteric artery.

Authors:  P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-07       Impact factor: 3.000

2.  Localization of monoamine oxidase of type A and B in blood vessels with different innervation patterns.

Authors:  M M Caramona
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

3.  Intra- and extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog.

Authors:  M Q Paiva; M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

4.  Evidence for an extraneuronal location of monoamine oxidase in renal tissues.

Authors:  M M Caramona; P Soares-da-Silva
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-05       Impact factor: 3.000

5.  Predominance of oxidative deamination in the metabolism of exogenous noradrenaline by the normal and chemically denervated human uterine artery.

Authors:  D Branco; M Caramona; F Martel; J A de Almeida; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-09       Impact factor: 3.000

6.  Effects of tryptamine mediated through 2 states of the 5-HT2 receptor in calf coronary artery.

Authors:  M Frenken; A J Kaumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-05       Impact factor: 3.000

7.  Effects of a monoamine oxidase A inhibitor, FLA 668 (+) on the adrenergic mechanisms of the dog saphenous vein.

Authors:  M M Caramona; J V Esplugues; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-11       Impact factor: 3.000

8.  The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.

Authors:  A Langeloh; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Influence of MAO A and MAO B on the inactivation of noradrenaline in the saphenous vein of the dog.

Authors:  M M Caramona; D Araújo; F Brandão
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

10.  Effects of clorgyline and (-)deprenyl on the deamination of normetanephrine and noradrenaline in strips and homogenates of the canine saphenous vein.

Authors:  M M Caramona; W Osswald
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.